“Closing the Gap: Sepsis Care in Underserved Communities”
Sepsis Alliance* and Cepheid* present…“Closing the Gap: Sepsis Care in Underserved Communities”
Socioeconomic status (SES) is a complex variable derived primarily from an individual’s education, income, and occupation and is inversely related to health outcomes. This presentation will review the data on sepsis incidence, epidemiology, care, and outcomes related to SES and race. Known barriers to healthcare access in infectious diseases affecting low-SES individuals, such as limited English proficiency, transportation, lack of insurance, and education, will be reviewed and implications for recognizing and minimizing these disparities in clinical practice will be addressed. In addition, how SES may affect outcomes of S. aureus bloodstream infections will be discussed.
Emi Minejima, PharmD | Associate Professor of Clinical Pharmacy | USC School of Pharmacy
Target Audience: Nurses & Pharmacists
Continuing Education: Nurses, earn 1.20 RN CE Contact Hours for this webinar. Pharmacists, earn 1.00 Contact Hour (.100 CEU) for this webinar. The University of Southern California School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education (CPE). This knowledge-based activity was assigned Universal Activity Numbers: 0007-9999-21-053-H04-P and 0007-9999-21-053-L04-P for 1.00 contact hour (0.100 CEU) with an initial release date of June 10, 2021 and expiration date of June 10, 2024. There is no fee to attend this program. To receive CPE credit for the CE activity, participants must complete the associated post-test/evaluation forms.
Sepsis Alliance gratefully acknowledges the support provided for this webinar by Cepheid*.
* NOTE: This is an industry resource-sponsored webinar. HealthTrust has not approved and/or endorsed the content. This program may contain the mention of products, services, drugs or brands presented in a case study or comparative format. Such examples are intended for educational and informational purposes and should not be perceived as a HealthTrust endorsement of any particular supplier, product, service, drug, brand or approach.